The Danish Medicines Act

Updated 30 March 2023

The Danish Medicines Act regulates the authorisation and control of medicinal products and the companies manufacturing, storing or otherwise handling medicinal products.

It also lays down rules on the reporting of adverse reactions to medicinal products and advertising of medicinal products. The authorisation of clinical trials in humans is also regulated by the Act.

The act is available in Danish at Retsinformation:

Lov om lægemidler (Lægemiddelloven) (Retsinformation)